What is iRadimed's EBITDA?

iRadimed (IRMD) reported EBITDA of $7.69M in Q1 2026.

How has iRadimed's EBITDA changed year-over-year?

iRadimed's EBITDA increased by 36.7% year-over-year, from $5.63M to $7.69M.

What is the long-term trend for iRadimed's EBITDA?

Over 3 years (2021 to 2025), iRadimed's EBITDA has grown at a 34.5% compound annual growth rate (CAGR), from $11.22M to $27.31M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

iRadimed IRMD EBITDA

EBITDA at other companies

Merit Medical SystemsMMSI

$74.65M+6.2%

ICU MedicalICUI

$63.61M+2.0%

ITG

Integer HoldingsITGR

$66.88M-15.8%

Lumexa Imaging Holdings, Inc. LMRI

$29.33M-15.2%

RadNetRDNT

$21.06M+85.1%

GE HealthCare TechnologiesGEHC

——

Other financials

Income statement

See full

Revenue$22.0M+12.6%

Gross profit$16.8M+13.3%

Operating income$7.2M+33.2%

Net income$5.8M+24.1%

EPS (diluted)$0.45+21.6%

Balance sheet

See full

Cash & equivalents$56.4M+12.0%

Total debt$59.2K-96.9%

Total equity$98.5M+9.4%

Total assets$114.4M+12.4%

Cash flow

See full

Operating cash flow$8.3M+93.2%

CapEx$403.0K-89.1%

Free cash flow$7.9M+1,226%

Valuation

See full

Market cap$1.21B+63.4%

P/E51.3×+13.8×

P/S14×+4.2×

Profitability

See full

Gross margin76.8%-0.1pp

Operating margin32.4%+2.3pp

Net margin27.4%+1.0pp

FCF margin28.4%+8.9pp

Returns & leverage

See full

Return on equity25%+1.2pp

Debt / equity0×0.0×

Current ratio7.1×-1.7×

Where this comes from

Calculated from iRadimed’s reported figures.

$7.2Mebit+

$455.0KDepreciation Depletion & Amortization

=$7.69M

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRadimed's EBITDA?: iRadimed (IRMD) reported EBITDA of $7.69M in Q1 2026.
How has iRadimed's EBITDA changed year-over-year?: iRadimed's EBITDA increased by 36.7% year-over-year, from $5.63M to $7.69M.
What is the long-term trend for iRadimed's EBITDA?: Over 3 years (2021 to 2025), iRadimed's EBITDA has grown at a 34.5% compound annual growth rate (CAGR), from $11.22M to $27.31M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.